Pfizer Deutschland is involved in the development and production of pharmaceuticals, including innovative medicines and vaccines. The company is known for its contributions to healthcare, particularly in the creation of treatments such as antibiotics, vitamins, and COVID-19 vaccines.

Pfizer Deutschland

Pharmaceutical Manufacturing

Pfizer CentreOne

Pfizer Medical

Anacor Pharmaceuticals

Biotechnology

Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc.

Pfizer | 6,054,564 followers on LinkedIn. We’re celebrating 175 years of daring scientific innovation—and we’re not done yet. Every day, we’re channeling our passion and resources into delivering innovative therapies that change the face of healthcare. Let’s outdo yesterday.

Candidate Experience - Recruitment for Pfizer Research and Development

Ted Clark

Talent Acquisition at Pfizer

Karen Michelson

Manager , Pfizer Pharmaceuticals

Timothy L. Anderson

Pfizer

Is the Medicine in Your Medicine Cabinet Safe? Unfortunately, there is a troubling lack of knowledge about counterfeits among U.S. healthcare providers. Therein lies opportunity in empowering health care providers and patients

Understanding proteins helps unlock new insights, develop innovative treatments, and drive scientific progress. To introduce our new #explainer series, which breaks down some of the scientific concepts central to our work at Pfizer, we’re exploring what proteins are and how they play a vital role in countless daily processes within our bodies. #Proteins #Innovation

Pfizer has been recognized in the top 25% of Forbes ' inaugural list of America's Best Employers for Tech Workers, where we are one of just four companies spotlighted in the Drug and Biotechnology category. Pfizer’s inclusion on this prestigious list is a testament to our dynamic and supportive culture, where every colleague has the opportunity to grow, excel, and make a meaningful impact. https://lnkd.in/gjmBJCbd

We’re supporting The Leukemia & Lymphoma Society as they work to define #BloodCancer and redefine what’s possible after diagnosis. Together, in partnership with the blood cancer community, we remain dedicated to making meaningful change to create a world where people with blood cancer live longer and better lives.

Today in a late-breaking presentation at ESMO - European Society for Medical Oncology 2024, we unveil new Phase 2 data in cancer cachexia, a life-threatening wasting condition with no FDA-approved treatments. Learn more about our #cachexia research: https://lnkd.in/eNS2kcB3 #Cachexia #ESMO24

We’re pleased to partner with the International Myeloma Foundation to raise awareness of the impact of #MultipleMyeloma . Our long-standing relationships with the community are imperative in understanding and supporting the unique needs of patients as we work to deliver breakthroughs in #BloodCancer and #kNOwMyeloma .

We're proud to partner with multidisciplinary stakeholders to support the IHI-SYNTHIA project – an initiative led by the Innovative Health Initiative aiming to revolutionize the field of personalized medicine by harnessing the power of synthetic data to improve health outcomes, including in cancer and #Hematology . #SYNTHIA

“You can’t do anything if you don’t have colleagues that are talented, that are motivated, that are driven by purpose.” A great message from my colleague Chris Boshoff, MD, PhD, FMedSci , and one with which I completely agree. Our Pfizer Oncology team exemplifies hard work, dedication, and above all, passion. We’re working tirelessly to develop a new generation of potential breakthroughs across cancers and tumor types that brings new hope to patients—because we’re united by the shared vision of a world where people with cancer live better and longer lives.

Albert Bourla

As part of Pfizer’s ambition to achieve the Net Zero Standard and RE100, we’re proud to partner with Vesper Energy and others to help generate new solar energy. Learn more below 👇

Really great event today in our NYC office celebrating Pride month.

PFIZ

DE:PFIZER

Pfizer Deutschland